Stock AMPE AMPIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 09:42:23 2024-04-29 EDT 		5-day change 1st Jan Change
0.32 USD -0.31% Intraday chart for Ampio Pharmaceuticals, Inc. -6.16% -84.39%
04-15 Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index CI
03-27 Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Company Profile

Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Sector
Biotechnology & Medical Research
Calendar
2024-05-08 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
AMPIO PHARMACEUTICALS, INC. Stock Ampio Pharmaceuticals, Inc.
-84.39% 364K
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.94% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.83% 95.28B
ARGENX SE Stock argenx SE
+2.71% 22.15B
BIONTECH SE Stock BioNTech SE
-16.17% 21.02B
GENMAB A/S Stock Genmab A/S
-8.40% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.99% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.39% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.66% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. AMPE Stock
  4. Funds and ETFs Ampio Pharmaceuticals, Inc.